DOP52 Guselkumab improves symptoms of fatigue in patients with moderately to severely active Ulcerative Colitis: Phase 3 QUASAR induction study results at Week 12

Saved in:
Bibliographic Details
Published in:Journal of Crohn's and colitis 2024-01, Vol.18 (Supplement_1), p.i166-i167
Main Authors: Dignass, A, Panés, J, Rubin, D T, Huang, K H G, Germinaro, M, Pandya, D, Han, C, Miao, Y, Zhang, H, Gu, F, Rowbotham, D, Mihaly, E, Bressler, B, Lichtenstein, G R, Allegretti, J R
Format: Article
Language:English
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1873-9946
1876-4479
DOI:10.1093/ecco-jcc/jjad212.0092